共有 50 笔近期内部人交易记录记录,涉及 SOC Telemed, Inc. (TLMD), 包括 25 笔买入 和 17 笔卖出. 内部人买入总额为 $669.8K 内部人卖出总额为 $310.73M.
近期活跃的重要内部人包括 Warburg Pincus & Co., Warburg Pincus Llc, Shulman Steven J. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TLMD
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2022-04-06 |
Warburg Pincus & Co. |
10 Percent Owner |
股份退回 |
33,874,965 |
$3.00 |
$101.62M |
- |
| 2022-04-06 |
Warburg Pincus Llc |
Director |
股份退回 |
33,874,965 |
$3.00 |
$101.62M |
- |
| 2022-04-06 |
Shulman Steven J |
Director |
股份退回 |
1,112,291 |
$3.00 |
$3.34M |
- |
| 2022-04-06 |
Fletcher David R. |
Officer |
未知 |
- |
- |
- |
- |
| 2022-04-06 |
Carella Thomas J. |
Other: Former Director |
股份退回 |
40,476 |
$2.48 |
$100.38K |
- |
| 2022-04-06 |
Greskoviak Joseph P |
Director |
股份退回 |
79,185 |
$3.00 |
$237.56K |
- |
| 2022-04-06 |
Warburg Pincus Partners Gp Llc |
Director |
股份退回 |
33,874,965 |
$3.00 |
$101.62M |
- |
| 2022-04-06 |
Kronfol Amr |
Other: Former Director |
股份退回 |
29,437 |
$2.48 |
$73K |
- |
| 2022-04-06 |
Mcgeorge Anne |
Director |
股份退回 |
58,387 |
$3.00 |
$175.16K |
- |
| 2022-04-06 |
Byrne Barbara Peterson |
Director |
股份退回 |
58,387 |
$3.00 |
$175.16K |
- |
| 2022-04-06 |
Hallock Robert Jason |
Chief Medical Officer |
股份退回 |
15,677 |
$3.00 |
$47.03K |
- |
| 2022-04-06 |
Kim Eunice |
General Counsel |
股份退回 |
22,168 |
$3.00 |
$66.5K |
- |
| 2022-04-06 |
Gallagher Christopher M. |
Chief Executive Officer |
其他(卖出) |
401,243 |
- |
- |
- |
| 2022-04-06 |
Chisley Gyasi C. |
Director |
股份退回 |
44,150 |
$3.00 |
$132.45K |
- |
| 2022-04-06 |
Mikula David |
Chief Operating Officer |
股份退回 |
496,576 |
$3.00 |
$1.49M |
- |
| 2022-04-01 |
Hallock Robert Jason |
Chief Medical Officer |
知情卖出 |
6,491 |
$2.98 |
$19.37K |
82,179 |
| 2021-12-20 |
Gallagher Christopher M. |
Director |
限制性股票授予 (RSU) |
720,000 |
- |
- |
720,000 |
| 2021-12-20 |
Mikula David |
Chief Operating Officer |
限制性股票授予 (RSU) |
300,000 |
- |
- |
300,000 |
| 2021-09-30 |
Fletcher David R. |
Officer |
未知 |
- |
- |
- |
- |
| 2021-09-01 |
Mikula David |
Chief Operating Officer |
处置 |
- |
- |
- |
496,576 |
| 2021-06-03 |
Shulman Steven J |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
1,712,887 |
| 2021-06-03 |
Carella Thomas J. |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
90,591 |
| 2021-06-03 |
Greskoviak Joseph P |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
74,270 |
| 2021-06-03 |
Kronfol Amr |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
101,325 |
| 2021-06-03 |
Mcgeorge Anne |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
58,387 |
| 2021-06-03 |
Byrne Barbara Peterson |
Director |
限制性股票授予 (RSU) |
21,067 |
- |
- |
58,387 |
| 2021-05-04 |
Chisley Gyasi C. |
Director |
未知 |
- |
- |
- |
- |
| 2021-05-04 |
Chisley Gyasi C. |
Director |
限制性股票授予 (RSU) |
44,150 |
- |
- |
44,150 |
| 2021-03-30 |
Gallagher Christopher M. |
Director |
未知 |
- |
- |
- |
401,243 |
| 2021-03-19 |
Greskoviak Joseph P |
Director |
限制性股票授予 (RSU) |
15,883 |
- |
- |
53,203 |
| 2021-02-16 |
Kalix John W. |
Chief Executive Officer |
限制性股票授予 (RSU) |
943,396 |
- |
- |
943,396 |
| 2021-01-28 |
Tran Hai |
President and COO |
限制性股票授予 (RSU) |
147,783 |
- |
- |
147,783 |
| 2021-01-28 |
Knibb Christopher K |
Chief Financial Officer |
限制性股票授予 (RSU) |
80,754 |
- |
- |
80,754 |
| 2021-01-28 |
Banerjee Sean |
Chief Technology Officer |
限制性股票授予 (RSU) |
59,113 |
- |
- |
59,113 |
| 2021-01-28 |
Hallock Robert Jason |
Chief Medical Officer |
限制性股票授予 (RSU) |
59,113 |
- |
- |
59,113 |
| 2021-01-28 |
Kim Eunice |
General Counsel |
限制性股票授予 (RSU) |
59,113 |
- |
- |
59,113 |
| 2021-01-05 |
Shulman Steven J |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
1,691,820 |
| 2021-01-05 |
Carella Thomas J. |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
69,524 |
| 2021-01-05 |
Greskoviak Joseph P |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
37,320 |
| 2021-01-05 |
Kronfol Amr |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
80,259 |
| 2021-01-05 |
Mcgeorge Anne |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
37,320 |
| 2021-01-05 |
Byrne Barbara Peterson |
Director |
限制性股票授予 (RSU) |
37,320 |
- |
- |
37,320 |
| 2021-01-04 |
Knibb Christopher K |
Officer |
未知 |
- |
- |
- |
- |
| 2020-10-30 |
Alyeska Investment Group, L.p. |
10 Percent Owner |
知情买入 |
199 |
$9.04 |
$1.8K |
24,804 |
| 2020-10-30 |
Shulman Steven J |
10 Percent Owner, Officer: Former Chief Executive Officer |
期权行权(卖出) |
4,375,000 |
- |
- |
- |
| 2020-10-30 |
Tran Hai |
Officer |
未知 |
- |
- |
- |
- |
| 2020-10-30 |
Tran Hai |
CFO and COO |
限制性股票授予 (RSU) |
169,533 |
$3.71 |
$628.97K |
169,533 |
| 2020-10-30 |
Carella Thomas J. |
Director |
未知 |
- |
- |
- |
- |
| 2020-10-30 |
Carella Thomas J. |
Director |
限制性股票授予 (RSU) |
7,885 |
$4.95 |
$39.03K |
7,885 |
| 2020-10-30 |
Greskoviak Joseph P |
Director |
未知 |
- |
- |
- |
- |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期